Brain Tumor Reports
54

Volume 18 Number 8
August 2016


Home > Publications > Brain Tumor Reports > Volume 18, Year 2016 > Number 8, August


CONTENTS



ATYPICAL TERATOID/RHABDOID TUMOR
EMBRYONAL TUMORS
GLIOBLASTOMA
GLIOMAS
-
DIFFUSE INTRINSIC PONTINE GLIOMA
-
HIGH-GRADE GLIOMAS
MEDULLOBLASTOMA







ATYPICAL TERATOID/RHABDOID TUMOR



PDQ Pediatric Treatment Editorial Board.
Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2016 Jul 12.
Source | Abstract | Full text (Book)







EMBRYONAL TUMORS



PDQ Pediatric Treatment Editorial Board.
Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2016 Jul 20.
Source | Abstract | Full text (Book)







GLIOBLASTOMA



Diagnosis and evaluation


Barajas RF Jr, Butowski NA, Phillips JJ, Aghi MK, Berger MS, Chang SM, Cha S.
The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma.
Acad Radiol. 2016 Sep;23(9):1073-82. doi: 10.1016/j.acra.2016.04.004. Epub 2016 Jul 18.
Source | Abstract | Full text | Similar articles




Bertaut A, Truntzer C, Madkouri R, Kaderbhai CG, Derangère V, Vincent J, Chauffert B, Aubriot-Lorton MH, Farah W, Mourier KL, Boidot R, Ghiringhelli F.
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
Oncotarget. 2016 Jul 28. doi: 10.18632/oncotarget.10898. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Etiology, pathogenesis and pathology


Capdevila C, Rodríguez Vázquez L, Martí J.
Glioblastoma Multiforme and Adult Neurogenesis in the Ventricular-Subventricular Zone: A Review.
J Cell Physiol. 2016 Jul 26. doi: 10.1002/jcp.25502. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
J Exp Clin Cancer Res. 2016 Jul 30;35(1):124. doi: 10.1186/s13046-016-0393-0.
Source | Abstract | Full text | Similar articles




Nguyen HS, Milbach N, Hurrell SL, Cochran E, Connelly J, Bovi JA, Schultz CJ, Mueller WM, Rand SD, Schmainda KM, LaViolette PS.
Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma.
AJNR Am J Neuroradiol. 2016 Aug 4. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Integrative medicine


Alexandru O, Georgescu AM, Ene L, Purcaru SO, Serban F, Popescu A, Brindusa C, Tataranu LG, Ciubotaru V, Dricu A.
The effect of curcumin on low-passage glioblastoma cells in vitro.
J Cancer Res Ther. 2016 Apr-Jun;12(2):1025-32. doi: 10.4103/0973-1482.167609. Epub 2016 Jul 25.
Source | Abstract | Full text | Similar articles




Rodriguez GA, Shah AH, Gersey ZC, Shah SS, Bregy A, Komotar RJ, Graham RM.
Investigating the therapeutic role and molecular biology of curcumin as a treatment for glioblastoma.
Ther Adv Med Oncol. 2016 Jul;8(4):248-60. doi: 10.1177/1758834016643518. Epub 2016 Apr 25.
Source | Abstract | Full text | Similar articles




Overall management


Mallick S, Benson R, Hakim A, Rath GK.
Management of glioblastoma after recurrence: A changing paradigm.
J Egypt Natl Canc Inst. 2016 Jul 28. pii: S1110-0362(16)30036-X. doi: 10.1016/j.jnci.2016.07.001. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Treatment


Carter T, Shaw H, Mulholland P.
Combining Ipilimumab and Bevacizumab in Glioblastoma: Is it Really Safe and Effective? Author Response.
Clin Oncol (R Coll Radiol). 2016 Jul 27. pii: S0936-6555(16)30187-X. doi: 10.1016/j.clon.2016.07.009. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Carter T, Shaw H, Cohn-Brown D, Chester K, Mulholland P.
Ipilimumab and Bevacizumab in Glioblastoma.
Clin Oncol (R Coll Radiol). 2016 May 8. pii: S0936-6555(16)30076-0. doi: 10.1016/j.clon.2016.04.042. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Fu P, He YS, Huang Q, Ding T, Cen YC, Zhao HY, Wei X.
Bevacizumab treatment for newly diagnosed glioblastoma: Systematic review and meta-analysis of clinical trials.
Mol Clin Oncol. 2016 May;4(5):833-838. Epub 2016 Mar 10.
Source | Abstract | Full text | Similar articles




Imber BS, Kanungo I, Braunstein S, Barani IJ, Fogh SE, Nakamura JL, Berger MS, Chang EF, Molinaro AM, Cabrera JR, McDermott MW, Sneed PK, Aghi MK.
Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience.
Neurosurgery. 2016 Jul 13. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kim C, Kim HS, Shim WH, Choi CG, Kim SJ, Kim JH.
Recurrent Glioblastoma: Combination of High Cerebral Blood Flow with MGMT Promoter Methylation Is Associated with Benefit from Low-Dose Temozolomide Rechallenge at First Recurrence.
Radiology. 2016 Jul 18:152152. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Platten M, Bunse L, Wick W, Bunse T.
Concepts in glioma immunotherapy.
Cancer Immunol Immunother. 2016 Jul 26. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Rios A, Hsu SH, Blanco A, Buryanek J, Day AL, McGuire MF, Brown RE.
Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamide.
Oncoscience. 2016 Jun 11;3(5-6):156-63. doi: 10.18632/oncoscience.311. eCollection 2016.
Source | Abstract | Full text | Similar articles




Tini P, Pirtoli L.
Combining Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and Effective?
Clin Oncol (R Coll Radiol). 2016 Jun 18. pii: S0936-6555(16)30121-2. doi: 10.1016/j.clon.2016.06.003. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Tosoni A, Franceschi E, Poggi R, Brandes AA.
Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences.
Curr Treat Options Oncol. 2016 Sep;17(9):49. doi: 10.1007/s11864-016-0422-4.
Source | Abstract | Full text | Similar articles




Weathers SP, Han X, Liu DD, Conrad CA, Gilbert MR, Loghin ME, O'Brien BJ, Penas-Prado M, Puduvalli VK, Tremont-Lukats I, Colen RR, Yung WK, de Groot JF.
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
J Neurooncol. 2016 Jul 12. [Epub ahead of print]
Source | Abstract | Full text | Similar articles







GLIOMAS



Follow-up and quality of life


Koekkoek JA, Dirven L, Taphoorn MJ.
The withdrawal of antiepileptic drugs in patients with low-grade and anaplastic glioma.
Expert Rev Neurother. 2016 Aug 2. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Treatment


Qi L, Ding L, Wang S, Zhong Y, Zhao D, Gao L, Wang W, Lv P, Xu Y, Wang S.
A network meta-analysis: the overall and progression-free survival of glioma patients treated by different chemotherapeutic interventions combined with radiation therapy (RT).
Oncotarget. 2016 Jul 21. doi: 10.18632/oncotarget.10763. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



DIFFUSE INTRINSIC PONTINE GLIOMA



Case reports


Pierre-Aurélien B, Alexandru S, Federico DR, Justyna K, Carmine M, Didier F.
Diffuse Intrinsic Pontine Glioma in Children: Document or Treat?
World Neurosurg. 2016 Jul 12. pii: S1878-8750(16)30533-2. doi: 10.1016/j.wneu.2016.07.011. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



HIGH-GRADE GLIOMAS



Follow-up and quality of life


Botturi A, Silvani A, Pravettoni G, Paoli RA, Lucchiari C.
Reversible Valproate Induced Pisa Syndrome and Parkinsonism in a Neuro-Oncology Patient with Depression and Epilepsy.
Case Rep Neurol. 2016 Jun 6;8(2):115-9. doi: 10.1159/000446643. eCollection 2016 May-Aug.
Source | Abstract | Full text | Similar articles




Prognosis and outcomes


Zhou X, Liao X, Zhang B, He H, Shui Y, Xu W, Jiang C, Shen L, Wei Q.
Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy.
Mol Clin Oncol. 2016 Aug;5(2):289-294. Epub 2016 Jun 15.
Source | Abstract | Full text | Similar articles




Treatment


Lin Y, Okada H.
Cellular immunotherapy for malignant gliomas.
Expert Opin Biol Ther. 2016 Jul 29:1-11. [Epub ahead of print]
Source | Abstract | Full text | Similar articles







MEDULLOBLASTOMA



Case reports


Miyata K, Hori T, Yamakawa K, Takasu M, Hayakawa T, Shimomura Y, Iwata A, Okumura A, Nakura T, Jyoko M, Mori Y, Takahashi E, Hirato J.
Medulloblastoma with epithelioid features in the cerebellar vermis.
Pediatr Int. 2016 Jul 24. doi: 10.1111/ped.12998. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Prognosis and outcomes


Kann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB.
Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children.
JAMA Oncol. 2016 Aug 4. doi: 10.1001/jamaoncol.2016.2547. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Paulino AC, Jaboin JJ.
Radiotherapy Deferral in Medulloblastoma.
JAMA Oncol. 2016 Aug 4. doi: 10.1001/jamaoncol.2016.2546. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sabel M, Fleischhack G, Tippelt S, Gustafsson G, Doz F, Kortmann R, Massimino M, Navajas A, von Hoff K, Rutkowski S, Warmuth-Metz M, Clifford SC, Pietsch T, Pizer B, Lannering B; SIOP-E Brain Tumour Group.
Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.
J Neurooncol. 2016 Jul 16. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Treatment


Collange NZ, Brito Sde A, Campos RR, Santos EA, Botelho RV; Sociedade Brasileira de Neurocirurgia.
Treatment of medulloblastoma in children and adolescents.
Rev Assoc Med Bras (1992). 2016 Jul;62(4):298-302. doi: 10.1590/1806-9282.62.04.298.
Source | Abstract | Full text | Similar articles




Collange NZ, Brito Sde A, Campos RR, Santos EA, Botelho RV.
Treatment of medulloblastoma in children and adolescents. (FAQ)
Rev Assoc Med Bras (1992). 2016 Jul;62(4):297. doi: 10.1590/1806-9282.62.04.297.
Source | Abstract | Full text | Similar articles




Gupta A, Kumar A, Abrari A, Patir R, Vaishya S.
Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.
World Neurosurg. 2016 Jul 20. pii: S1878-8750(16)30568-X. doi: 10.1016/j.wneu.2016.07.044. [Epub ahead of print]
Source | Abstract | Full text | Similar articles